Stages of the pathologic process in alzheimer disease: Age categories from 1 to 100 years

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 11, 2011, Pages 960-969

  Braak, Heiko ^a   Thal, Dietmar R ^b   Ghebremedhin, Estifanos ^a,b   Del Tredici, Kelly ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

A amyloid; Alzheimer disease; Brainstem; Hyperphosphorylated tau protein; Locus coeruleus; Neuropil threads; Pretangles neurofibrillary tangles

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN STEM; CHILD; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LOCUS CERULEUS; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PYRAMIDAL NERVE CELL; SCHOOL CHILD; TAUOPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; SILVER STAINING; STATISTICS, NONPARAMETRIC; TAU PROTEINS; YOUNG ADULT;

EID: 80054904670     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318232a379     Document Type: Article

References (75)

1. Nelson PT, Braak H, Markesbery WR. Neuropathology and cognitive impairment in Alzheimer's disease: A complex but coherent relationship. J Neuropathol Exp Neurol 2009;68:1-14
2. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
3. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351-57 (Pubitemid 27435070)
4. Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer diseaseY associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404 (Pubitemid 44469160)
5. Thal DR, Rüb U, Schultz C, et al. Sequence of Ab-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 2000;59: 733-48 (Pubitemid 30626743)
6. Thal DR, Rüb U, Orantes M, et al. Phases of Ab-deposition in the human brain and its relevance for the development of AD. Neurology 2002;58: 1791-1800 (Pubitemid 34663580)
7. Alafuzoff I, Arzberger T, Al-Sarraj S, et al. Staging of neurofibrillary pathology in Alzheimer's disease: A study for the BrainNet Europe Consortium. Brain Pathol 2008;18:484-96
8. Braak H, Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 2011;121:171-81
9. Goedert M, Jakes R, Crowther RA, et al. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 1993;90:5066-70 (Pubitemid 23182977)
10. Trojanowski JQ, Lee VMY. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann N Y Acad Sci 2000;924:62-67 (Pubitemid 32050184)
11. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006;314:777-81 (Pubitemid 44706636)
12. Goedert M, Klug A, Crowther RA. Tau protein, the paired helical filament and Alzheimer's disease. J Alzheimers Dis 2006;9(Suppl):195-207 (Pubitemid 44253313)
13. Mattson MP. Molecular and cellular pathways towards and away from Alzheimer's disease. In: Jucker M, Beyreuther K, Haass C, Nitsch R, Christen Y, eds. Alzheimer: 100 Years and Beyond. Berlin, Germany: Springer, 2006:371-78
14. Mandelkow E, von Bergen M, Biernat J, et al. Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain Pathol 2007;17:83-90
15. Kovacech B, Skrabana R, Novak M. Transition of tau protein from disordered to misordered in Alzheimer's disease. Neurodegenerat Dis 2010; 7:24-27
16. Dickson DW. Neuropathology of non-Alzheimer degenerative disorders. Int J Clin Exp Pathol 2009;25:1-23
17. Braak H, Braak E. Argyrophilic grains: Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 1987;76:124-27 (Pubitemid 17052293)
18. Ferrer I, Santpere G, van Leeuwen FW. Argyrophilic grain disease. Brain 2008;131:1416-32 (Pubitemid 351806447)
19. Tolnay M, Probst A. Argyrophilic grain disease. Handb Clin Neurol 2008; 89:553-63
20. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991;1:213-16
21. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinsons disease. Neurobiol Aging 2003;24:197-210
22. Beach TG, Adler CH, Sue SI, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010;119:689-702
23. Pikkarainen M, Martikainen P, Alafuzoff I. The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Appl Neurol 2010;69:40-52
24. German DC, White CL, Sparkman DR. Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 1987;21:305-12 (Pubitemid 17099011)
25. Hertz L. Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells? Brain Res Rev 1989;14:335-53 (Pubitemid 20042044)
26. Parvizi J, Van Hoesen GW, Damasio A. The selective vulnerability of brainstem nuclei to Alzheimer's disease. Ann Neurol 2001;49:53-66 (Pubitemid 32163006)
27. Grinberg LT, Rüb U, Ferretti REL, et al. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Neuropathol Appl Neurobiol 2009;35:406-16
28. Geula C, Nagykery N, Nicholas A, et al. Cholinergic and axonal abnormalities are present early in aging and Alzheimer disease. J Neuropathol Exp Neurology 2008;67:309-18 (Pubitemid 351507486)
29. Simic G, Stanic G, Mladinov M, et al. Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol 2009;35:532-54
30. Zweig RM, Ross CA, Hedreen JC, et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 1988;24:233-42
31. Busch C, Bohl J, Ohm TG. Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging 1997;18: 401-6 (Pubitemid 27435082)
32. Zarow C, Lyness SA, Mortimer JA, et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 2003;60:337-41 (Pubitemid 36314358)
33. Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus norepinephrine function: Adaptive gain and optimal performance. Ann Rev Neurosci 2005;28:403-50 (Pubitemid 41098911)
34. Haglund M, Sjöbeck M, Englund E. Locus coeruleus degeneration is ubiquitous in Alzheimer's disease: Possible implications for diagnosis and treatment. Neuropathology 2006;26:528-32 (Pubitemid 44800288)
35. Grudzien A, Shaw P, Weintraub S, et al. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 2007;28:327-35 (Pubitemid 46178530)
36. Muresan Z, Muresan V. Seeding neuritic plaques from the distance: A possible role for brainstem neurons in the development of Alzheimer's disease pathology. Neurodegenerative Dis 2008;5:250-53 (Pubitemid 351347864)
37. Weinshenker D. Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr Alzheimer Res 2008;5:342-45 (Pubitemid 351840281)
38. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 2009;10:211-23
39. Pearson J, Goldstein M, Markey K, et al. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 1983;8:3-32 (Pubitemid 13175353)
40. Bobinski M, Wegiel J, Tarnawski M, et al. Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res 1998;799: 156-58 (Pubitemid 28351215)
41. Morsch R, Simon W, Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 1999;58:188-97 (Pubitemid 29088942)
42. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994;87:554-67 (Pubitemid 24158408)
43. Yankner BA, Lu T, Loerch P. The aging brain. Ann Rev Pathol 2008;3: 41-66 (Pubitemid 351488276)
44. Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature 2010;464:529-35
45. Herrup K. Reimagining Alzheimer's diseaseVan age-based hypothesis. J Neurosci 2010;30:16755-62
46. Frautschy SA, Cole GM. Why pleiotropic interventions are needed for Alzheimer's disease. Mol Neurobiol 2010;41:392-409
47. Martinez A, Porteo-Otin M, Pamplona R, et al. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 2010;20:281-97
48. Patten DA, Germain M, Kelly MA, et al. Reactive oxygen species: Stuck in the middle of neurodegeneration. J Alzheimers Dis 2010;20:357-67
49. Hyman BT, Goméz-Isla T. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 1994;15:353-54 (Pubitemid 24194877)
50. Nelson PT, Head E, Schmitt FA, et al. Alzheimer's disease is not "brain aging": Neuropathological, genetic, and epidemiological human studies. Acta Neuropathol 2011:121:571-87
51. Ohm TG, Müller H, Braak H, Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's diseaseY related neurofibrillary changes. Neuroscience 1995;64:209-17
52. Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer's disease: Successive emergence of clinical symptoms. Ann Neurol 2008;64:492-98
53. Lemere CA, Blusztajn JK, Yamaguchi H, et al. Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol Dis 1996;3:16-32
54. Leverenz JB, Raskind MA. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: A regional quantitative analysis. Exp Neurol 1998;150:296-304 (Pubitemid 28231961)
55. Del Tredici K, Braak H. Neurofibrillary changes of the Alzheimer type in very elderly individuals: Neither inevitable nor benign. Commentary on "No disease in the brain of a 115-year-old woman." Neurobiol Aging 2008;29:1133-36 (Pubitemid 351822421)
56. Li B, Chohan MO, Grundke-Iqbal I, et al. Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol 2007;113:501-11 (Pubitemid 46672596)
57. Alonso AC, Li B, Grundke-Iqbal I, et al. Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr Alzheimer Res 2008;5:375-84
58. Iqbal K, Liu F, Gong CX, et al. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 2009;118:53-69
59. Cowan CM, Bossing T, Page A, et al. Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol 2010;120:593-604
60. Stamer K, Vogel R, Thies E, et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 2002;156:1051-63 (Pubitemid 34839854)
61. Sassin I, Schultz C, Thal DR et al. Evolution of Alzheimer's diseaseY related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 2000;100:259-69 (Pubitemid 30456152)
62. Hardy JA. The amyloid hypothesis: History and alternatives. In: Jucker M, Beyreuther K, Haass C, et al, eds. Alzheimer: 100 Years and Beyond. Berlin, Germany: Springer, 2006:151-56
63. Hardy JA, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002;297: 353-56 (Pubitemid 34790756)
64. Braak H, Del Tredici K. Alzheimer's disease: Intraneuronal alterations precede insoluble amyloid-A formation. Neurobiol Aging 2004;25:713-18 (Pubitemid 38698242)
65. Schönheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 2004;25:697-711 (Pubitemid 38698241)
66. Korczyn AD. The amyloid cascade hypothesis. Alzheimers Dement 2008;4:176-78 (Pubitemid 351682258)
67. Pimplikar SW. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. Int J Biochem Cell Biol 2009;41:1261-68
68. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-28
69. Götz J, Chen F, van Dorpe J, et al. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001; 293:1491-95 (Pubitemid 32807681)
70. Lewis J, Dickson DW, Lin WL, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001; 293:1487-91 (Pubitemid 32801551)
71. Oddo S, Billings L, Kesslak JP, et al. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004;43:321-32 (Pubitemid 39061125)
72. Whittington RA, Virág L, Marcouiller F, et al. Propofol directly increases tau phosphorylation. PLoS One 2011;6:e16648
73. Braak H, Del Tredici K. Alzheimer's pathogenesis: Is there neuronto-neuron propagation? Acta Neuropathol 2011;121:589-95
74. Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010; 33:317-25
75. Guo JL, Lee VM. Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 2011; 286: 15317-31